#AbLec

The secret is out! 🚀 Thrilled to support Valora's mission to bring our #AbLec technology to patients, alongside co-inventor @carolynbertozzi.bsky.social. More to come, and in the meantime, you can learn more about AbLecs here:
www.biorxiv.org/content/10.1...

Carolyn Bertozzi’s latest biotech debuts with $30M seed round and a sugary spin on immunotherapy Valora Therapeutics has $30 million to jumpstart research on immunotherapies based on sugars — the kind that dots cell surfaces and help devastating cancers evade immune system attack.

Congratulations to the Valora Therapeutics team on an exciting launch; it is a privilege to work with cofounders @jcstark.bsky.social at MIT/Koch Inst and biotech veteran/CEO Miguel Garcia-Guzman, bringing the #AbLec technology to patients. #glycotime

endpts.com/carolyn-bert...